COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 1 for:    Piclidenoson | Plaque Psoriasis
Previous Study | Return to List | Next Study

CF101 Therapy in Patients With Moderate-to-severe Plaque Psoriasis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03168256
Recruitment Status : Active, not recruiting
First Posted : May 30, 2017
Last Update Posted : March 31, 2020
Information provided by (Responsible Party):
Can-Fite BioPharma

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : February 15, 2021
Estimated Study Completion Date : December 15, 2021